Inspire Investing’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Sell
8,999
-100
-1% -$6.42K 0.03% 840
2026
Q1
$513K Buy
9,099
+3,272
+56% +$213K 0.03% 736
2025
Q4
$467K Sell
5,827
-3,498
-38% -$235K 0.04% 566
2025
Q3
$455K Buy
9,325
+4,098
+78% +$254K 0.04% 539
2025
Q2
$390K Sell
5,227
-214
-4% -$14.2K 0.04% 523
2025
Q1
$346K Buy
5,441
+304
+6% +$20.7K 0.04% 392
2024
Q4
$401K Buy
5,137
+7
+0.1% +$562 0.04% 528
2024
Q3
$412K Buy
5,130
+845
+20% +$68.3K 0.04% 569
2024
Q2
$354K Buy
4,285
+67
+2% +$5.89K 0.04% 425
2024
Q1
$360K Sell
4,218
-259
-6% -$20.3K 0.04% 484
2023
Q4
$383K Buy
4,477
+1,048
+31% +$90.6K 0.04% 658
2023
Q3
$307K Sell
3,429
-7,377
-68% -$659K 0.04% 538
2023
Q2
$920K Buy
10,806
+7,532
+230% +$637K 0.11% 215
2023
Q1
$271K Buy
3,274
+267
+9% +$21.6K 0.03% 749
2022
Q4
$237K Buy
3,007
+212
+8% +$17K 0.03% 427
2022
Q3
$207K Sell
2,795
-423
-13% -$30.4K 0.03% 482
2022
Q2
$210K Sell
3,218
-533
-14% -$31.5K 0.03% 739
2022
Q1
$237K Sell
3,751
-793
-17% -$43.1K 0.03% 420
2021
Q4
$241K Buy
4,544
+1,178
+35% +$71.8K 0.03% 771
2021
Q3
$238K Buy
+3,366
New +$212K 0.03% 435
2018
Q1
Sell
-984
Closed -$57K 400
2017
Q4
$57K Buy
+984
New +$51.8K 0.05% 465

Other funds holding HAE

Inspire Investing's HAE Position: Q2 2026 in Review

Inspire Investing reduced its Haemonetics (HAE) stake by 1.1% in Q2 2026, selling an estimated $6.42K and leaving 8,999 shares worth $675K. The position accounts for 0.03% of the portfolio, ranked #840.

Inspire Investing first reported a position in HAE in Q4 2017 and has held it in 21 quarters since. The position peaked at $920K in Q2 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Inspire Investing held 8,999 shares of Haemonetics worth $675K as of Q2 2026.
  • Inspire Investing sold 100 Haemonetics shares in Q2 2026, an estimated $6.42K.
  • Haemonetics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #840 holding.
  • Inspire Investing first reported a position in Haemonetics in Q4 2017 and has held it in 21 quarters since.
  • Inspire Investing's Haemonetics position peaked at $920K in Q2 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.